Reduced Analgesics Consumption and Pain Intensity after Injections with a New Hyaluronic Acid in Patients with Knee Osteoarthritis

1. Jevsevar DS - Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg 21(9):571–57610.5435/00124635-201309020-00008Search in Google Scholar

2. Balazs E - Viscosupplementation for osteoarthritis. from initial discovery to current status and results, Surg. Technol. Int. 12 (2004) 278–289.Search in Google Scholar

3. Balazs E, Denlinger J - Viscosupplementation – a new concept in the treatment of osteoarthritis, J. Rheumatol. 20 (1993) 3–9.Search in Google Scholar

4. Qvist P, Bay-Jensen A, Christiansen C et al. - The disease modifying osteoarthritis drug (DMOAD): is it in the horizon?, Pharmacol Res. 58 (2008) 1–7.10.1016/j.phrs.2008.06.00118590824Open DOISearch in Google Scholar

5. Strauss E, Hart J, Miller M, et al. - Hyaluronic acid viscosupplementation and osteoarthritis: current uses and future directions, Am. J. Sports Med. 37 (2009) 1636–1644.10.1177/036354650832698419168804Search in Google Scholar

6. Moreland L, Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action, Arthritis Res. Ther. 5 (2003) 54–67.10.1186/ar62316503312718745Open DOISearch in Google Scholar

7. Vincent HK, Montero C, Conrad BP, et al. - “Functional Pain,” Functional Outcomes, and Quality of Life After Hyaluronic Acid Intra-articular Injection for Knee Osteoarthritis. PM R. 2013 Apr;5(4):310-810.1016/j.pmrj.2013.01.00423416148Search in Google Scholar

8. Altman RD, Manjoo A, Fierlinger A, et al. - The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review. BMC Musculoskelet Disord. 2015; 16: 32110.1186/s12891-015-0775-z462187626503103Search in Google Scholar

9. Smith MM, Russell AK, Schiavinato A, et al. - A hexadecylamide derivative of hyaluronan (HYMOVIS®) has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronan. Journal of Inflammation (London, England). 2013;10:26.10.1186/1476-9255-10-26372795823889808Search in Google Scholar

10. Shimizu C. Kubo T, Hirasawa Y, et al. - Histomorphometric and biochemical effect of various hyaluronans on early osteoarthritis. J Rheumatol. 1998 Sep;25(9):1813-9.Search in Google Scholar

11. Newberry SJ, Fitzgerald JD, Maglione MA, et al. - Systematic Review for Effectiveness of Hyaluronic Acid in the Treatment of Severe Degenerative Joint Disease (DJD) of the Knee [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Jul.Search in Google Scholar

12. Bagga H, Burkhardt D, Sambrook P, et al. - Longterm effects of intraarticular hyaluronan on synovial fluid in osteoarthritis of the knee. J Rheumatol. 2006;33(5):946-50Search in Google Scholar

13. Skwara A, Peterlein CD, Tibesku CO, et al. - Changes of gait patterns and muscle activity after intraarticular treatment of patients with osteoarthritis of the knee: a prospective, randomised, doubleblind study. Knee. 2009 Dec;16(6):466-72.10.1016/j.knee.2009.03.00319362003Open DOISearch in Google Scholar

14. Wang F, He X - Intra-articular hyaluronic acid and corticosteroids in the treatment of knee osteoarthritis: A meta-analysis. Exp Ther Med. 2015 Feb; 9(2): 493–500.10.3892/etm.2014.2131428093925574222Search in Google Scholar

15. Creamer P - Intra-articular corticosteroid treatment in osteoarthritis. Curr Opin Rheumatol. 1999 Sep;11(5):417-21.10.1097/00002281-199909000-0001610503664Open DOISearch in Google Scholar

16. McAlindon TE - OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014 Mar;22(3):363-8810.1016/j.joca.2014.01.003Search in Google Scholar

17. Carter GT, Duong V, Ho S, et al. - Side effects of commonly prescribed analgesic medications. Phys Med Rehabil Clin N Am. 2014 May;25(2):457-70.10.1016/j.pmr.2014.01.007Search in Google Scholar

18. Nuesch E, Rutjes AW, Husni E, Welch V, Juni P. Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane Database Syst Rev 2009;(4):CD003115.10.1002/14651858.CD003115.pub3Search in Google Scholar

19. Rosemann T, Laux G, Szecsenyi J. Osteoarthritis: quality of life, comorbidities, medication and health service utilization assessed in a large sample of primary care patients. J Orthop Surg Res. 2007 Jun 30;2:12.10.1186/1749-799X-2-12Search in Google Scholar

20. Michael JW, Schlüter-Brust KU, Eysel P. The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int. 2010 Mar;107(9):152-62.10.3238/arztebl.2010.0152Search in Google Scholar

21. Scott J - Vertical or horizontal visual analogue scales. Ann Rheum Dis. 1979; 38:560. 4. McCormack HM, Horne DJL, Sheather S. Clinical applications of visual analogue scales: a critical review. Psychol Med. 1988; 18:1007–19.10.1017/S0033291700009934Search in Google Scholar

22. Jensen MP - The measurement of clinical pain intensity: a comparison of six methods. Pain 1986; 27: 117–26.10.1016/0304-3959(86)90228-9Open DOISearch in Google Scholar

23. Burckhardt CS - Adult measures of pain: The McGill Pain Questionnaire (MPQ), Rheumatoid Arthritis Pain Scale (RAPS), Short-Form McGill Pain Questionnaire (SF-MPQ), Verbal Descriptive Scale (VDS), Visual Analog Scale (VAS), and West Haven-Yale Multidisciplinary Pain Inventory (WHYMPI). Arthritis Rheum 2003; 49: S96–104.10.1002/art.11440Search in Google Scholar

24. Romanian National Institute of Statistics - “Population by ethnicity 2011”Search in Google Scholar

25. Smith MM, Russell AK, Schiavinato A, et al. - A hexadecylamide derivative of hyaluronan (HYMOVIS®) has superior beneficial effects on human osteoarthritic chondrocytes and synoviocytes than unmodified hyaluronan. J Inflamm (Lond). 2013 Jul 27;10:26.10.1186/1476-9255-10-26372795823889808Search in Google Scholar

26. Finelli I, Chiessi E, Galesso D, et al. - A new viscosupplement based on partially hydrophobic hyaluronic acid: a comparative study. Biorheology. 2011;48(5):263-75.10.3233/BIR-2011-059622433568Search in Google Scholar

27. Benazzo F, Perticarini L, Padolino A, et al. - A multi-centre, open label, long-term follow-up study to evaluate the benefits of a new viscoelastic hydrogel (Hymovis®) in the treatment of knee osteoarthritis. Eur Rev Med Pharmacol Sci. 2016 Mar;20(5):959-68.Search in Google Scholar

28. Conrozier T, Eymard F, Afif N, et al. - Safety and efficacy of intraarticular injections of a combination of hyaluronic acid and mannitol (HAnOX-M) in patients with symptomatic knee osteoarthritis: Results of a double-blind, controlled, multicenter, randomized trial. Knee. 2016 Oct;23(5):842-8.10.1016/j.knee.2016.05.01527353769Search in Google Scholar

29. Askari A, Gholami T, NaghiZadeh MM, et al. - Hyaluronic acid compared with corticosteroid injections for the treatment of osteoarthritis of the knee: a randomized control trail.Search in Google Scholar

30. Ray TR - Using viscosupplementation to treat knee osteoarthritis. Phys Sportsmed. 2013 Nov;41(4):16-24.10.3810/psm.2013.11.203224231593Search in Google Scholar

31. Food and Drug Administration. Clinical Development Programs for Drugs, Devices, and Biological Products Intended for the Treatment of Osteoarthritis. Draft Guidance. Washington, DC: FDA; July 1999.Search in Google Scholar